These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10065507)

  • 1. [Photosensitization caused by 5-fluorouracil (5-FU)].
    von Moos R; Sauter C
    Schweiz Med Wochenschr; 1999 Jan; 129(1-2):52. PubMed ID: 10065507
    [No Abstract]   [Full Text] [Related]  

  • 2. Lichenoid photosensitive eruption due to capecitabine chemotherapy for metastatic breast cancer.
    Hague JS; Ilchyshyn A
    Clin Exp Dermatol; 2007 Jan; 32(1):102-3. PubMed ID: 16879449
    [No Abstract]   [Full Text] [Related]  

  • 3. Photosensitive lichenoid drug eruption to capecitabine.
    Walker G; Lane N; Parekh P
    J Am Acad Dermatol; 2014 Aug; 71(2):e52-3. PubMed ID: 25037814
    [No Abstract]   [Full Text] [Related]  

  • 4. Atypical moles in a patient undergoing chemotherapy with oral 5-fluorouracil prodrug.
    Fukushima S; Hatta N
    Br J Dermatol; 2004 Sep; 151(3):698-700. PubMed ID: 15377362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute heart failure after treatment with 5-fluorouracil.
    Georgieva S; Kinova E; Iordanov V; Gudev A; Tzekova V; Velikova M
    J BUON; 2007; 12(1):113-6. PubMed ID: 17436411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of late-onset severe cardiotoxicity from 5-fluorouracil therapy resulting in death.
    Wijesinghe N
    N Z Med J; 2007 Nov; 120(1266):U2836. PubMed ID: 18264205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-SSA/Ro antibody as a risk factor for fluorouracil-induced drug eruptions showing acral erythema and discoid-lupus-erythematosus-like lesions.
    Adachi A; Nagai H; Horikawa T
    Dermatology; 2007; 214(1):85-8. PubMed ID: 17191054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inflammatory effect of systemic fluorouracil in actinic keratosis.
    Nabai H; Mohindra R; Mehregan D
    Cutis; 1999 Jul; 64(1):43-4. PubMed ID: 10431671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
    Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized pustular drug eruption caused by topical 5-fluorouracil.
    Nemer KM; Solus JF; Schaffer A; Rosman IS; Lee SJ
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28834062
    [No Abstract]   [Full Text] [Related]  

  • 11. Vasospastic angina caused by 5-fluorouracil. A case report.
    Pop C; Nica R; Vlaicu R; Vinereanu D
    Rom J Intern Med; 2003; 41(4):433-7. PubMed ID: 15526525
    [No Abstract]   [Full Text] [Related]  

  • 12. Photosensitivity from oral administration of a fluorouracil derivative (FT 207).
    Sun CC; Hsu SC
    Photodermatol; 1984 Apr; 1(2):94-5. PubMed ID: 6442417
    [No Abstract]   [Full Text] [Related]  

  • 13. Healing of colon anastomoses covered with fibrin glue after immediate postoperative intraperitoneal administration of 5-fluorouracil.
    Kanellos I; Mantzoros I; Demetriades H; Kalfadis S; Kelpis T; Sakkas L; Betsis D
    Dis Colon Rectum; 2004 Apr; 47(4):510-5. PubMed ID: 14978614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous side-effects caused by Tegafur.
    Revenga F
    Int J Dermatol; 1999 Dec; 38(12):955-7. PubMed ID: 10671104
    [No Abstract]   [Full Text] [Related]  

  • 15. Paraneoplastic dermatomyositis triggered and exacerbated by oral 5-fluorouracil administration.
    Kawachi Y; Koike Y; Kano T; Furuta J; Fujisawa Y; Nakamura Y; Ishii Y; Takahashi T; Otsuka F
    Eur J Dermatol; 2008; 18(2):195-6. PubMed ID: 18424388
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coronary vasospasm during 5-fluorouracil chemotherapy].
    Sucker C; Scheffold N
    Dtsch Med Wochenschr; 2001 Nov; 126(46):1300-1. PubMed ID: 11709733
    [No Abstract]   [Full Text] [Related]  

  • 17. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute encephalopathy attributed to 5-FU.
    Langer CJ; Hageboutros A; Kloth DD; Roby D; Shaer AH
    Pharmacotherapy; 1996; 16(2):311-3. PubMed ID: 8820478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of an adverse reaction to topical 5-fluorouracil in irradiated skin.
    Lambert T; Mullinax K; Smith J
    J Drugs Dermatol; 2006 Mar; 5(3):282-3. PubMed ID: 16573264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral signs of intravenous chemotherapy with 5-Fluorouracil and Leucovorin calcium in colon cancer treatment.
    Mazzeo MA; Linares JA; Campos ML; Busamia BE; Dubersarsky C; Lavarda M; Jarchum G; Finkelberg AB
    Med Oral Patol Oral Cir Bucal; 2009 Mar; 14(3):E108-13. PubMed ID: 19242388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.